3 min read
Benefits of Establishing a Full-Time Equivalent (FTE) Program
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants pharmaceutical and biotech companies the flexibility,...
1 min read
Alcami : Aug 31, 2023 1:49:00 PM
The FDA has issued Guidance for Industry, Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol, May2023, Revision 1. The contamination of diethylene glycol (DEG) and ethylene glycol (EG) in high-risk drug components has been linked to fatal poisonings of consumers.
To ensure the safety and quality of medicines, the guidance has issued recommendations for preventing DEG and EG contamination. These recommendations include the following:
A partnership with Alcami’s analytical team can provide support to remain in compliance and to ensure the continued safety of your drug components and drug product. Alcami has experience testing the following drug components for DEG and EG and perform testing without the need for further establishment work:
Alcami’s years of compendial and validation experience can provide support in development of new methods for other high-risk drug components that do not have a method within the monograph or covered in USP <469>.
3 min read
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants pharmaceutical and biotech companies the flexibility,...
1 min read